Trial · NCT07907185
Total Hip Replacement: an Investigation of Robotic-assisted Versus conVentional Surgery and Patient-centred outcomEs
NCT07907185, Not applicable, Not yet recruiting, Hamilton Health Sciences Corporation
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Total Hip Replacement: an Investigation of Robotic-assisted Versus conVentional Surgery and Patient-centred outcomEs. Trials, record NCT07907185. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907185
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Total Hip Replacement: an Investigation of Robotic-assisted Versus conVentional Surgery and Patient-centred outcomEs
- NCT number
- NCT07907185
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 90 participants, estimated
- Lead sponsor
- Hamilton Health Sciences Corporation
- Conditions
- Osteo Arthritis Knee and Hip
- Interventions
- MAKO Robotic System (Stryker, USA), Conventional Total Hip Arthroplasty
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Feasibility Outcomes | 6 months | Recruitment, allocated intervention, and protocol adherence, completion of follow-up among those due, and key data completeness. |
| Secondary | Forgotten Joint Score-12 (FJS-12) | 6 weeks and 6 months after surgery. | Awareness of the operated hip during everyday activities will be assessed using the 12-item Forgotten Joint Score. Responses are converted to a total score ranging from 0 to 100. Higher scores indicate less awareness of the artificial joint and a better outcome. |
| Secondary | Oxford Hip Score (OHS) | 6 weeks and 6 months after surgery. | Hip pain and function will be assessed using the Oxford Hip Score, a 12-item patient-reported questionnaire. Item scores are summed to produce a total score ranging from 0 to 48. Higher scores indicate less pain and better hip function. |
| Secondary | Euro-Qol 5 Dimensions (EQ-5D) | 6 weeks and 6 months after surgery. | Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire. It assesses five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, coded from 1 (no problems) to 5 (extreme problems or inability to perform the activity). Higher levels indicate worse health within that dimension. |
| Secondary | Patient Satisfaction With Hip Replacement | 6 weeks and 6 months after surgery. | Overall satisfaction with the operated hip will be assessed using five response categories: very satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied, or very dissatisfied. The number and percentage of participants in each category will be reported. |
| Secondary | Surgical Complications | 6 weeks and 6 months after surgery. | Prespecified complications include intraoperative or postoperative periprosthetic fracture, superficial or deep surgical site infection, prosthetic dislocation, implant failure or aseptic loosening, and reoperation. Other clinically important surgical complications will also be recorded. |
| Secondary | Safety Outcomes | 6 weeks and 6 months after surgery. | Any adverse or serious adverse events will be collected where applicable for trial monitoring. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07907185
GET https://conductscience.org/api/trials/v1/NCT07907185/registered